- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
BioMarin Pharmaceutical Inc+ Add to Watchlist
BM8:GR50.060 EUR 0.206 0.41%
As of 02:08:23 ET on 05/17/2013.
Company Profile for BioMarin Pharmaceutical Inc (BM8)
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
BioMarin Pharmaceutical Inc
Key Executives for BioMarin Pharmaceutical Inc (BM8)
|Jean-Jacques BienaimeChief Executive Officer||Daniel K Spiegelman "Dan"Exec VP/CFO|
|Henry J FuchsExec VP/Chief Medical Officer||Robert A BaffiExec VP:Technical Operations|
|Jeff AjerSenior VP/Chief Commercial Ofcr||G Eric DavisSenior VP/Secretary/Gen Cnsl|
|Mark WoodSenior VP:HR & Corp Affairs||Brian R MuellerVP/Chief Acctg Ofcr/Controller|
|Eugenia ShenInvestor Relations|